Skip to main content
. 2015 Dec;5(4):691–700. doi: 10.1086/683813

Table 6.

12-week ranolazine concentration

Patient Ranolazine, μmol/L
1 3.11
3 0.94
4 1.53
5 4.23
6 BQL
8a 1.53
10a 1.33
11a 1.65
12a 2.62
13 0.13
Note

Boldface indicates a therapeutic concentration. BQL: below quantitation limit (50.0 ng/mL).

a

Patients in 12-week open-label extension.